Journal
INFLAMMATION
Volume 45, Issue 1, Pages 234-252Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10753-021-01541-9
Keywords
programmed cell death factor 4 (PDCD4); mitogen-activated protein kinases (MAPKs); nuclear factor-kappa B (NF-kappa B); microglia; neuroinflammation; neuron apoptosis
Categories
Funding
- Scientific Research Project of Health Commission of Jiangsu Province [H2018035, H2019057, LGY2017042]
- Nantong Science and Technology Project [JC2019031, JCZ19106, JC2021015, JC2021179, JCZ20078]
- Top Six Types of Financial Assistance of Jiangsu Province [2019-WSW-199]
Ask authors/readers for more resources
The study found that PDCD4 may serve as a key regulatory molecule in central nervous system neuroinflammation and oxidative stress-induced neuronal apoptosis, regulating both microglial inflammatory activation and neuronal apoptosis, forming a positive feedback loop. This discovery provides a new perspective for potential therapeutic targets in neuroinflammatory diseases.
Neuroinflammation and neuron injury are common features of the central nervous system (CNS) diseases. It is of great significance to identify their shared key regulatory molecules and thus explore the potential therapeutic targets. Programmed cell death factor 4 (PDCD4), an apoptosis-related molecule, extensively participates in tumorigenesis and inflammatory diseases, but its expression and biological function during CNS neuroinflammation remain unclear. In the present study, utilizing the lipopolysaccharide (LPS)-induced neuroinflammation model in mice, we reported an elevated expression of PDCD4 both in injured neurons and activated microglia of the inflamed brain. A similar change in PDCD4 expression was observed in vitro in the microglial activation model. Silencing PDCD4 by shRNA significantly inhibited the phosphorylation of MAPKs (p38, ERK, and JNK), prevented the phosphorylation and nuclear translocation of NF-kappa B p65, and thus attenuated the LPS-induced microglial inflammatory activation. Interestingly, LPS also required the MAPK/NF-kappa B signaling activation to boost PDCD4 expression in microglia, indicating the presence of a positive loop. Moreover, a persistent elevation of PDCD4 expression was detected in the H2O2-induced neuronal oxidative damage model. Knocking down PDCD4 significantly inhibited the expression of pro-apoptotic proteins BAX and Cleaved-PARP, suggesting the proapoptotic activity of PDCD4 in neurons. Taken together, our data indicated that PDCD4 may serve as a hub regulatory molecule that simultaneously promotes the microglial inflammatory activation and the oxidative stress-induced neuronal apoptosis within CNS. The microglial PDCD4-MAPK-NF-kappa B positive feedback loop may act as pivotal signaling for neuroinflammation which subsequently exaggerates neuronal injury, and thus may become a potential therapeutic target for neuroinflammatory diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available